What if boosting the immune system treated late-stage and metastatic ovarian cancer? 

Ovarian cancer, our initial test case, needs novel, effective, and non-toxic treatment strategies. Macrophage engineered vesicles are a platform technology that harnesses the power of immune cell-derived extracellular vesicles to modulate the tumor microenvironment. This is a paradigm shift in the field of extracellular vesicles, where instead of isolating extracellular vesicles released by cells, we are engineering them from the cell of interest. This retains desirable cancer targeting and tumor microenvironment modulation properties and overcomes previously insurmountable challenges in yield. 

Topic 6: Revolutionary Breakthroughs